Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis-Reference-Cited by-同舟云学术

Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis

Published:2018-10-10 Issue:1 Volume:180 Page:76-85
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Leonardi C.¹,Papp K.²^ORCID,Strober B.³^ORCID,Thaçi D.⁴,Warren R.B.⁵,Tyring S.⁶,Arikan D.⁷,Karunaratne M.⁷,Valdecantos W.C.⁷

Affiliation:

1. Department of Dermatology St. Louis University St. Louis MO U.S.A

2. Probity Medical Research and K. Papp Clinical Research Waterloo ON Canada

3. Department of Dermatology and Probity Medical Research University of Connecticut Farmington CT U.S.A

4. Comprehensive Center for Inflammation Medicine University of Lübeck Lübeck Germany

5. Dermatology Centre Salford Royal NHS Foundation Trust NIHR Manchester Biomedical Research Centre The University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT U.K

6. Department of Dermatology University of Texas Health Science Center at Houston Houston TX U.S.A

7. AbbVie Inc. North Chicago IL U.S.A

Funder

AbbVie

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17084

Reference31 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials

3. Biologic safety in psoriasis: review of long‐term safety data;Mansouri Y;J Clin Aesthet Dermatol,2015

4. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic

5. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials;Dermatology and Therapy;2023-06-23

2. Skin Cancer Correlations in Psoriatic Patients;Cancers;2023-04-25

3. Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel;Dermatology and Therapy;2023-03-16

4. Editorial: Autoimmune pre-disease;Frontiers in Immunology;2023-02-14

5. Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy;American Journal of Ophthalmology;2022-08